|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
s Influences Its Association with the µ-Opioid Receptor and Is Modulated by Long-Term Morphine ExposureDepartment of Biochemistry, State University of New York, Downstate Medical Center, Brooklyn, New York
The recent biochemical demonstration of the association of the µ-opioid receptor (MOR) with G
s that increases after long-term morphine treatment (Mol Brain Res 135:217–224, 2005) provides a new imperative for studying MOR-G
s interactions and the mechanisms that modulate it. A persisting challenge is to elucidate those neurochemical parameters modulated by long-term morphine treatment that facilitate MOR-G
s association. This study demonstrates that 1) G
s exists as a phosphoprotein, 2) the stoichiometry of G
s phosphorylation decreases after long-term morphine treatment, and 3) in vitro dephosphorylation of G
s increases its association with MOR. Furthermore, our data suggest that increased association of G
s with protein phosphatase 2A is functionally linked to the long-term morphine treatment-induced reduction in G
s phosphorylation. These findings are observed in MOR-Chinese hamster ovary and F11 cells as well as spinal cord, indicating that they are not idiosyncratic to the particular cell line used or a "culture" phenomenon and generalize to complex neural tissue. Taken together, these results indicate that the phosphorylation state of G
s is a critical determinant of its interaction with MOR. Long-term morphine treatment decreases G
s phosphorylation, which is a key mechanism underlying the previously demonstrated increased association of MOR and G
s in opioid tolerant tissue.
Received for publication March 19, 2007.
Accepted for publication June 15, 2007.
Address correspondence to: Dr. Alan Gintzler, Box 8, Department of Biochemistry, SUNY Downstate Medical Center, 450 Clarkson Ave., Brooklyn, NY 11203. E-mail: alan.gintzler{at}downstate.edu
This article has been cited by other articles:
![]() |
P. Fan, Z. Jiang, I. Diamond, and L. Yao Up-Regulation of AGS3 during Morphine Withdrawal Promotes cAMP Superactivation via Adenylyl Cyclase 5 and 7 in Rat Nucleus Accumbens/Striatal Neurons Mol. Pharmacol., September 1, 2009; 76(3): 526 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Gintzler and S. Chakrabarti The Ambiguities of Opioid Tolerance Mechanisms: Barriers to Pain Therapeutics or New Pain Therapeutic Possibilities J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 709 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shy, S. Chakrabarti, and A. R. Gintzler Plasticity of Adenylyl Cyclase-Related Signaling Sequelae after Long-Term Morphine Treatment Mol. Pharmacol., March 1, 2008; 73(3): 868 - 879. [Abstract] [Full Text] [PDF] |
||||